Clinical trials
Screening Tool clinical trials
Below are recruiting screening tool clinical trials, each written for real people, not researchers. We’re tracking 41 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06743308Recruiting
New questionnaire to improve understanding in advanced lung cancer
This study tests a new questionnaire to help people with advanced lung cancer better understand their illness. It is for patients who are being treated at MD Anderson and were recently diagnosed.
Houston, TexasAges 18 years+ - NCT06682650Recruiting
Colorectal cancer screening tool for Spanish-speaking communities
This study tests if a new tool can help clinics in Spanish-speaking communities get more people screened for colorectal cancer. If you are an adult 45–75 who is due for screening and get care at a participating clinic, you may be eligible.
Aurora, ColoradoAges 45–75 - NCT06506877Enrolling by invitation
A tool to screen for cognitive risk in primary care
This study is testing a new tool to help primary care providers spot early signs of thinking or memory problems in older adults. If you are a provider who sees patients aged 60 and up and can prescribe medicine, you may be able to join.
Cleveland, OhioAges Any age - NCT06221020Recruiting
Enhanced recovery after pituitary tumor surgery
This study tests a standard care plan to help patients recover faster after surgery to remove a pituitary tumor. It may reduce hospital stay and improve recovery.
Kaohsiung CityAges 20–75 - NCT05384535Recruiting
Test a special MRI to screen high-risk prostate cancer
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
Lake Success, New YorkAges 40–55 - NCT04873258Recruiting
Test a non-invasive tool to screen for fat-related liver disease
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
London, LondonAges 18–80 - NCT04561791Enrolling by invitation
Testing a swallowable scope for early detection of Barrett’s esophagus
This study checks whether a special swallowable “camera capsule” test done in primary care can find early warning changes called Barrett’s esophagus. If it works well, it could make screening easier for people at risk.
Boston, MassachusettsAges 18–75 - NCT06538636Recruiting
Improving lung cancer screening for Veterans
This study is testing a new way to find Veterans who might benefit from yearly lung cancer screening. It uses a computer model to estimate your personal benefit, even if you don't fit the usual screening guidelines.
Bedford, MassachusettsAges 50–80 - NCT04171830Enrolling by invitation
Screening for palliative needs in the last year of life
This trial uses a special tool to check if patients in the hospital have unmet needs for comfort and quality-of-life care. It is designed for patients who may be in their final year of life, helping doctors and nurses offer extra support sooner.
Brampton, OntarioAges Any age - NCT07302165Enrolling by invitation
Online tool to screen and prevent postpartum depression in parents-to-be
This trial tests a digital tool to find and help parents at risk for depression after childbirth. You may qualify if you have certain thinking patterns or risk factors during pregnancy.
CopenhagenAges 18 years+ - NCT06738173Recruiting
Gut bacteria test to screen for colorectal cancer
This trial tests a new tool that looks at gut bacteria to help find colorectal cancer earlier. It's for people who already had a positive result on a standard stool test (FIT) as part of a national screening program.
Rome, RMAges 50–74 - NCT07475611Enrolling by invitation
Screen-based rehab for visual neglect after stroke
This study tests whether an interactive screen helps people with left-sided neglect after a stroke. It includes adults who had a right-sided stroke and have trouble paying attention to the left side of their world.
Buenos Aires, EscobarAges 18–88 - NCT06619106Recruiting
Screening tool for minimal hepatic encephalopathy
This study tests a new cognitive tool to quickly and reliably detect minimal hepatic encephalopathy, a subtle brain change that can occur in people with liver disease. If you have a liver condition like fibrosis or cirrhosis and are already scheduled for a full evaluation (neuropsychological tests, MRI, EEG, and blood ammonia), this tool could help simplify future screening.
ParisAges 18–70 - NCT07631624Recruiting
Blood test for lung cancer screening in smokers and former smokers
This study tests whether a simple blood test that detects smoking-related changes in DNA can help identify who should get lung cancer screening. Researchers want to see if this test is better at finding people at risk than current methods.
Antwerp, AntwerpenAges 50 years+ - NCT06329531Recruiting
Validating a tool for cancer survivors in rehab
This study tests a new questionnaire that helps occupational therapists understand the needs of cancer survivors. It is for patients already receiving care at a physical medicine and rehabilitation (PMR) clinic to see how well the tool works.
Houston, TexasAges 18 years+ - NCT06934239RecruitingPhase 4
AI-assisted vs. standard mammograms for breast cancer screening
This trial compares standard mammograms with mammograms aided by artificial intelligence (AI) to see if AI helps find breast cancer more accurately and reduces unnecessary callbacks. If you're 18 or older and getting a routine screening mammogram at one of the six participating health systems, you may be eligible.
Los Angeles, CaliforniaAges 18 years+ - NCT03915418Recruiting
Screening sleep problems in children with cerebral palsy
This trial checks a new way to find sleep problems in children with cerebral palsy using connected tools (like devices/apps). It mainly helps by making sleep screening easier and more accurate, so families can get the right next steps sooner.
AngersAges 6–15
Hear when a new Screening Tool trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for screening tool?
- Yes. Clin2 currently lists 41 recruiting screening tool studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a screening tool trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a screening tool trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.